![Russell Greig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell Greig
Presidente presso
Mint Solutions Holding BV
Patrimonio netto: 75 $ in data 31/03/2026
Profilo
Russell G.
Greig is currently Chairman at AM-Pharma Holding BV, Mint Solutions Holding BV (since 2014), Sanifit, Inc. (since 2015), BiomX Ltd. (since 2019), and Non-Executive Chairman at Nucleome Therapeutics Ltd. (since 2023).
He is Independent Chairman at Cardior Pharmaceuticals GmbH (since 2022).
He serves as Director at Edinburgh BioQuarter and as Member of the Scottish Science Advisory Council.
Former roles include Chief Executive Officer at Genocea Biosciences, Inc. (2009–2011), Chairman & Chief Executive Officer at Novavax AB (2012–2013), Chairman at Novagali Pharma SA (2011–2012), Chairman at Bionor Pharma ASA (2015–2016), Chairman at eTheRNA immunotherapies NV (2016–2023), Chairman at Ipsen Bioinnovation Ltd. (2011–2013), Independent Non-Executive Director at TiGenix NV (2012–2018), Independent Director at Valerio Therapeutics SA (2013–2017), President at GSK Equity Investments Ltd (2008–2009), President-SR One at GSK Plc (2008–2010), and Venture Partner at Kurma Partners SA (2012–2017).
Other former positions include Chairman at Merus NV, Bird Rock Bio Sub, Inc., AM-Pharma BV, Sanifit Therapeutics SA, Horama SA, and Cumulus Oncology Ltd., Director at Oryzon Genomics SA, Melinta Subsidiary Corp., and Ablynx NV (2012–2018).
Education includes undergraduate and doctorate degrees from The University of Manchester.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 03/02/2026 | 20 ( 0% ) | 75 $ | 31/03/2026 |
Posizioni attive di Russell Greig
| Società | Posizione | Inizio |
|---|---|---|
Scottish Science Advisory Council | Corporate Officer/Principal | - |
Edinburgh BioQuarter
 Edinburgh BioQuarter Miscellaneous Commercial ServicesCommercial Services Provides research and development services on drugs | Direttore/Membro del Consiglio | - |
Mint Solutions Holding BV
 Mint Solutions Holding BV Medical SpecialtiesHealth Technology Develops and manufactures medication safety system | Presidente | 01/09/2014 |
Sanifit, Inc.
 Sanifit, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Presidente | 01/07/2015 |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology Engages in financial investment and shareholding activities | Presidente | - |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Presidente | 01/10/2019 |
Cardior Pharmaceuticals GmbH
 Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts | Presidente | 06/04/2022 |
Nucleome Therapeutics Ltd.
 Nucleome Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecular drugs for autoimmune diseases | Presidente | 06/09/2023 |
Precedenti posizioni note di Russell Greig
| Società | Posizione | Fine |
|---|---|---|
| BIOMX INC. | Presidente | 04/03/2026 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Russell Greig
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
69
Relazioni di 1° grado
31
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 31 |
|---|---|
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
TiGenix NV
 TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Develops, manufactures, and sells vaccine adjuvants | Health Technology |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Oryzon Genomics SA
 Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics | Health Technology |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for eye treatment | Health Technology |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology Engages in financial investment and shareholding activities | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Bird Rock Bio Sub, Inc.
 Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Health Technology |
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance KP invests in startups located in Europe. The firm targets companies operating in the fields of healthcare services and health technologies. It provides financing for seed to growth stage capital requirements. | Finance |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Manufactures nutritional supplements and vaccines | Health Technology |
Scottish Science Advisory Council | |
Edinburgh BioQuarter
Edinburgh BioQuarter Miscellaneous Commercial ServicesCommercial Services Provides research and development services on drugs | Commercial Services |
Mint Solutions Holding BV
Mint Solutions Holding BV Medical SpecialtiesHealth Technology Develops and manufactures medication safety system | Health Technology |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Health Technology |
Sanifit, Inc.
Sanifit, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Horama SA
 Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases | Health Technology |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts | Health Technology |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Cumulus Oncology Ltd.
 Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
BiomX, Inc.
 BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
Nucleome Therapeutics Ltd.
Nucleome Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecular drugs for autoimmune diseases | Health Technology |
